Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05415761 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care

A NA study of Tobacco Use Cessation, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
1,332
Enrollment target
1
Study location

NCT05415761 is a NA study of Tobacco Use Cessation that is actively recruiting participants, run by University of Florida. The registered enrollment target is 1,332 participants, above the 848-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (57% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05415761, a NA study of Tobacco Use Cessation, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
1,332 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the comparative effectiveness of three smoking cessation therapies: mobile health (mHealth) application iCanQuit, mHealth application iCanQuit + Motiv8, and the Florida quit line.

Conditions Studied

Interventions

  • BEHAVIORAL iCanQuit
  • BEHAVIORAL iCanQuit+Motiv8
  • BEHAVIORAL Florida quit line

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 1,332 participants
Start Date 2023-05-15
Est. Completion 2027-12-31
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05415761

The ClinicalTrials.gov registry entry for NCT05415761 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,332 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 848-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (57% higher). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 3 interventions - of which iCanQuit is the first listed.

NCT05415761 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05415761 about?

NCT05415761 is a clinical study titled "Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care". This study will evaluate the comparative effectiveness of three smoking cessation therapies: mobile health (mHealth) application iCanQuit, mHealth application iCanQuit + Motiv8, and the Florida quit line.

What is the current status of trial NCT05415761?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,332 participants. The study started on 2023-05-15. Estimated completion is 2027-12-31.

What conditions does trial NCT05415761 study?

This clinical trial studies the following conditions: Tobacco Use Cessation.

What interventions are being tested in trial NCT05415761?

The interventions under investigation include: iCanQuit (BEHAVIORAL), iCanQuit+Motiv8 (BEHAVIORAL), Florida quit line (BEHAVIORAL).

Who is sponsoring clinical trial NCT05415761?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05415761 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.